InnoPharmax Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	199.06	166.73	39.36	40.53	90.51	181.4
Short-Term Investments	44.5	114.5	100.3	55.85	96.76	60.49
Cash & Short-Term Investments	243.56	281.23	139.66	96.37	187.26	241.89
Cash Growth	106.23%	101.37%	44.91%	-48.54%	-22.58%	43.66%
Accounts Receivable	5.57	4.53	6.96	-	-	11.72
Other Receivables	0.87	0.47	0.82	0.57	4.03	4.32
Receivables	6.44	5	7.78	0.57	4.03	16.04
Inventory	27.46	19.33	25.53	30.5	16.12	49.23
Prepaid Expenses	1.47	1.47	3.38	1.1	1.92	1.23
Other Current Assets	12.69	13.26	12.65	8.2	-	3.48
Total Current Assets	291.62	320.29	188.99	136.74	209.33	311.87
Property, Plant & Equipment	5.83	8.59	13.77	19.57	13.77	20.57
Long-Term Investments	255.27	261.21	269.14	278.43	283.97	299.39
Other Intangible Assets	5.78	6.22	6.72	8.85	9.75	12.62
Long-Term Accounts Receivable	-	-	6.09	6.09	6.09	-
Long-Term Deferred Tax Assets	19.4	19.4	21.72	21.72	21.72	21.72
Other Long-Term Assets	17.95	17.35	17.75	17.92	11.53	14.02
Total Assets	595.85	633.06	524.2	489.31	556.16	680.18
Accounts Payable	6.03	2.4	6.7	0.84	0.84	37.02
Accrued Expenses	1.58	0	0	0.23	0.04	0.06
Short-Term Debt	16.5	10	11.5	23.27	-	20
Current Portion of Leases	3.1	4.57	4.48	4.42	4.5	4.42
Current Unearned Revenue	4.78	2.44	0.18	0.18	0.18	0.18
Other Current Liabilities	10.89	9.98	11.09	10.19	8.66	141.45
Total Current Liabilities	42.87	29.4	33.95	39.13	14.22	203.12
Long-Term Leases	0.02	0.82	5.39	9.86	1.08	5.49
Other Long-Term Liabilities	-	-	9.32	9.32	9.32	-
Total Liabilities	42.89	30.22	48.65	58.31	24.61	208.61
Common Stock	1,076	1,076	949.97	868.36	867.19	765.46
Additional Paid-In Capital	100.43	100.43	34.17	0.77	52.86	-
Retained Earnings	-623.16	-572.96	-507.84	-437.48	-386.89	-293.98
Comprehensive Income & Other	-0.07	-0.44	-0.75	-0.66	-1.61	0.09
Shareholders' Equity	552.96	602.85	475.55	431	531.54	471.57
Total Liabilities & Equity	595.85	633.06	524.2	489.31	556.16	680.18
Total Debt	19.61	15.39	21.36	37.56	5.57	29.9
Net Cash (Debt)	223.95	265.84	118.29	58.82	181.69	211.99
Net Cash Growth	122.91%	124.73%	101.12%	-67.63%	-14.29%	57.46%
Net Cash Per Share	2.16	2.73	1.28	0.68	2.10	2.77
Filing Date Shares Outstanding	107.58	107.58	95	86.84	86.72	76.55
Total Common Shares Outstanding	107.58	107.58	95	86.84	86.72	76.55
Working Capital	248.75	290.89	155.05	97.61	195.11	108.74
Book Value Per Share	5.14	5.60	5.01	4.96	6.13	6.16
Tangible Book Value	547.18	596.62	468.82	422.15	521.8	458.95
Tangible Book Value Per Share	5.09	5.55	4.94	4.86	6.02	6.00
Machinery	35.67	35.67	35.14	34.74	36.97	35.52
Leasehold Improvements	0.66	0.66	0.66	0.66	0.66	0.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.